MA48970B1 - Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate - Google Patents
Utilisation de l'oleoresine de copaifera dans les pathologies de la prostateInfo
- Publication number
- MA48970B1 MA48970B1 MA48970A MA48970A MA48970B1 MA 48970 B1 MA48970 B1 MA 48970B1 MA 48970 A MA48970 A MA 48970A MA 48970 A MA48970 A MA 48970A MA 48970 B1 MA48970 B1 MA 48970B1
- Authority
- MA
- Morocco
- Prior art keywords
- prostate diseases
- copaifera oleoresin
- copaifera
- oleoresin
- prostate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1752284A FR3063906B1 (fr) | 2017-03-20 | 2017-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
| EP18711130.7A EP3600370B1 (fr) | 2017-03-20 | 2018-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
| PCT/EP2018/057076 WO2018172380A1 (fr) | 2017-03-20 | 2018-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA48970A MA48970A (fr) | 2021-03-31 |
| MA48970B1 true MA48970B1 (fr) | 2024-06-28 |
Family
ID=59153043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA48970A MA48970B1 (fr) | 2017-03-20 | 2018-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11311591B2 (https=) |
| EP (1) | EP3600370B1 (https=) |
| JP (1) | JP7305546B2 (https=) |
| KR (1) | KR102686593B1 (https=) |
| CN (1) | CN110494149A (https=) |
| AU (1) | AU2018240405B2 (https=) |
| BR (1) | BR112019018744B1 (https=) |
| CA (1) | CA3056293A1 (https=) |
| ES (1) | ES2979106T3 (https=) |
| FR (1) | FR3063906B1 (https=) |
| MA (1) | MA48970B1 (https=) |
| MX (1) | MX2019011118A (https=) |
| PL (1) | PL3600370T3 (https=) |
| WO (1) | WO2018172380A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020089944A1 (en) * | 2018-11-03 | 2020-05-07 | Olene Life Sciences Private Limited | Process for preparing an herbal extract and compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH698144B1 (fr) * | 2003-09-24 | 2009-05-29 | Bioxell Spa | Analogue de la vitamine D3 |
-
2017
- 2017-03-20 FR FR1752284A patent/FR3063906B1/fr active Active
-
2018
- 2018-03-20 CA CA3056293A patent/CA3056293A1/fr active Pending
- 2018-03-20 MX MX2019011118A patent/MX2019011118A/es unknown
- 2018-03-20 BR BR112019018744-8A patent/BR112019018744B1/pt active IP Right Grant
- 2018-03-20 PL PL18711130.7T patent/PL3600370T3/pl unknown
- 2018-03-20 US US16/495,771 patent/US11311591B2/en active Active
- 2018-03-20 WO PCT/EP2018/057076 patent/WO2018172380A1/fr not_active Ceased
- 2018-03-20 ES ES18711130T patent/ES2979106T3/es active Active
- 2018-03-20 MA MA48970A patent/MA48970B1/fr unknown
- 2018-03-20 EP EP18711130.7A patent/EP3600370B1/fr active Active
- 2018-03-20 AU AU2018240405A patent/AU2018240405B2/en active Active
- 2018-03-20 KR KR1020197028071A patent/KR102686593B1/ko active Active
- 2018-03-20 CN CN201880018902.4A patent/CN110494149A/zh active Pending
- 2018-03-20 JP JP2019551555A patent/JP7305546B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019132832A3 (https=) | 2021-06-11 |
| MA48970A (fr) | 2021-03-31 |
| EP3600370B1 (fr) | 2024-04-03 |
| BR112019018744A2 (pt) | 2020-04-07 |
| FR3063906B1 (fr) | 2025-12-12 |
| JP2020511488A (ja) | 2020-04-16 |
| PL3600370T3 (pl) | 2024-07-29 |
| BR112019018744B1 (pt) | 2023-02-23 |
| KR102686593B1 (ko) | 2024-07-18 |
| KR20190126091A (ko) | 2019-11-08 |
| AU2018240405A1 (en) | 2019-11-07 |
| CA3056293A1 (fr) | 2018-09-27 |
| RU2019132832A (ru) | 2021-04-21 |
| EP3600370C0 (fr) | 2024-04-03 |
| EP3600370A1 (fr) | 2020-02-05 |
| FR3063906A1 (fr) | 2018-09-21 |
| ES2979106T3 (es) | 2024-09-24 |
| AU2018240405B2 (en) | 2024-04-11 |
| US20200093879A1 (en) | 2020-03-26 |
| WO2018172380A1 (fr) | 2018-09-27 |
| US11311591B2 (en) | 2022-04-26 |
| CN110494149A (zh) | 2019-11-22 |
| MX2019011118A (es) | 2019-11-05 |
| JP7305546B2 (ja) | 2023-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501575A1 (en) | ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF | |
| JOP20210129A1 (ar) | مثبطات apol1 وطرق استخدامها | |
| EA202090655A1 (ru) | Комбинированные терапевтические средства и их применение | |
| MX2017013533A (es) | Composiciones de limpieza personal concentradas. | |
| EA202091964A1 (ru) | КОМБИНИРОВАННЫЙ ПРОДУКТ НА ОСНОВЕ ИНГИБИТОРА Bcl-2 И ИНГИБИТОРА MDM2 И ЕГО ПРИМЕНЕНИЕ В ПРЕДУПРЕЖДЕНИИ И/ИЛИ ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ | |
| MA45029B1 (fr) | Anticorps anti pd-1 et anti-lag3 pour le traitement du cancer | |
| EP4272834A3 (en) | Therapeutic use of mitochondria and combined mitochondrial agents | |
| EA201690265A3 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
| MX2017015574A (es) | Inhibidores de tirosina quinasa de bruton. | |
| MA43335B1 (fr) | Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr | |
| GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| EA201992595A1 (ru) | Усиление фармакокинетики бифункциональных хелатов и их применения | |
| MX2022014457A (es) | Formulaciones de inmunoconjugado anti-cd79b estables. | |
| MX375752B (es) | Inhibidores de tirosina quinasa de bruton. | |
| PH12022551105A1 (en) | Tyk2 pseudokinase ligands | |
| MX2021009555A (es) | Ligandos de pseudocinasa tyk2. | |
| MX2019002960A (es) | Oligonucleótidos modificados y métodos de uso. | |
| EA202192625A1 (ru) | Лиганды псевдокиназы tyk2 | |
| MX2022000712A (es) | Moduladores de nlrp3. | |
| MX2017013534A (es) | Composiciones concentradas para la limipieza personal y usos. | |
| EA202192047A1 (ru) | Соединения и их применение | |
| SA521430519B1 (ar) | مثبطات مسار تبادل إشارات التحزيز واستخدامها في علاج السرطانات | |
| PH12021550033A1 (en) | Tumor reduction formulations and methods of use thereof | |
| ZA202000354B (en) | Novel braf inhibitors and use thereof for treatment of cutaneous reactions | |
| MA48970B1 (fr) | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |